Showing results (161-170 of 190) with videos related to
Sort By:
Pageof 19
Carbohydrate Research|March 19, 2019
Advances in chemical modifications of starches and their applicationsFazal Haq, Haojie Yu, Li Wang, et al.Cancer|October 28, 2015
Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patientsWeibin Wang, Xingyun Su, Kuifeng He, et al.Annals of Surgical Oncology|February 1, 2021
A Comparison of the Seventh and Eighth Editions of the AJCC Staging Systems to Predict Recurrence in Papillary Thyroid MicrocarcinomaZhendong Chen, Jiaying Ruan, Yunjin Yao, et al.Plos One|July 19, 2012
Lin28 mediates paclitaxel resistance by modulating p21, Rb and Let-7a miRNA in breast cancer cellsKezhen Lv, Liqun Liu, Linbo Wang, et al.Molecular Oncology|March 19, 2013
Estrogen receptor-α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cellsGuangliang Li, Jing Zhang, Ketao Jin, et al.Cancer Chemotherapy and Pharmacology|May 28, 2015
A phase II study of biweekly S-1 and paclitaxel (SPA) as first-line chemotherapy in patients with metastatic or advanced gastric cancerHaiping Jiang, Jiong Qian, Peng Zhao, et al.Plos One|December 14, 2011
Assessment of a novel VEGF targeted agent using patient-derived tumor tissue xenograft models of colon carcinoma with lymphatic and hepatic metastasesKetao Jin, Guangliang Li, Binbin Cui, et al.Journal of Translational Medicine|September 30, 2022
Microbiota and metabolites alterations in proximal and distal gastric cancer patientsYan Yang, Daofeng Dai, Wen Jin, et al.Cell Death & Disease|March 21, 2026
Fatty acid oxidation drives acetyl-CoA-dependent H3K9ac reprogramming to promote adaptive resistance to BRAF<sup>V600E</sup> inhibition in thyroid cancerXumeng Wang, Jing Zhang, Jimeng Yuan, et al.Frontiers in Immunology|January 26, 2023
Genomic and transcriptomic analysis of MSI-H colorectal cancer patients with targetable alterations identifies clinical implications for immunotherapyHanju Hua, Wenguang He, Nan Chen, et al.Pageof 19